The goal of this activity is to expand the knowledge base of clinicians who treat patients with severe asthma through a case-based discussion and interactive polling questions. After completing the activity, participants will demonstrate: (1) Increased knowledge regarding the pathophysiology of severe eosinophilic asthma; (2) Improved competence regarding current guideline-based strategies for assessing and adjusting treatment to improve asthma control; (3) Increased knowledge regarding emerging therapies for patients with uncontrolled symptoms of severe asthma.

FACULTY
Michael E. Wechsler, MD, MMSc, National Jewish Health, Denver, Colorado
Mario Castro, MD, MPH, Washington University, St. Louis, Missouri
Parameswaran Nair, MD, PhD, McMaster University, Hamilton, Ontario

COURSE DIRECTOR
Lanny Rosenwasser, MD, University of Missouri at Kansas City, Kansas City, Missouri

ACCREDITATION STATEMENT
Medscape, LLC is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

CREDITS AVAILABLE
Medscape, LLC designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits(TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded on 5 December 2017 in Jerusalem, Israel.
Developed through a partnership between the World Allergy Organization and Medscape Education.
Supported by an independent educational grant from Teva Pharmaceuticals.

Follow the link to the course online at Medscape.